Yu-Hsin Lin
Chief Executive Officer at Belite Bio Inc
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 6 months
- Director since
- 2026
6 months of board service in total across 1 board, counting each seat separately. Longest: Belite Bio Inc, 6 months.
Belite Bio Inc
Director · Chief Executive Officer
Chief executive roles
Belite Bio Inc
· Chief Executive Officer
Since March 2026
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 8, 2026 | Belite Bio Inc | Open-market sale | −2,400 | $194.33 | $466,399 |
| Sep 8, 2026 | Belite Bio Inc | Open-market sale | −6,090 | $195.62 | $1,191,325 |
| Sep 8, 2026 | Belite Bio Inc | Open-market sale | −6,058 | $196.54 | $1,190,642 |
| Sep 8, 2026 | Belite Bio Inc | Open-market sale | −8,752 | $197.36 | $1,727,275 |
| Sep 8, 2026 | Belite Bio Inc | Open-market sale | −2,700 | $198.09 | $534,845 |
| Sep 4, 2026 | Belite Bio Inc | Open-market sale | −2,635 | $180.29 | $475,071 |
| Sep 4, 2026 | Belite Bio Inc | Open-market sale | −2,587 | $181.24 | $468,877 |
| Sep 4, 2026 | Belite Bio Inc | Open-market sale | −3,413 | $182.50 | $622,869 |
| Sep 4, 2026 | Belite Bio Inc | Open-market sale | −4,955 | $183.30 | $908,228 |
| Sep 4, 2026 | Belite Bio Inc | Open-market sale | −6,252 | $184.52 | $1,153,647 |
| Sep 4, 2026 | Belite Bio Inc | Open-market sale | −4,593 | $185.34 | $851,286 |
| Sep 4, 2026 | Belite Bio Inc | Open-market sale | −7,800 | $186.32 | $1,453,323 |
| Sep 4, 2026 | Belite Bio Inc | Open-market sale | −6,200 | $187.25 | $1,160,964 |
| Sep 4, 2026 | Belite Bio Inc | Open-market sale | −3,045 | $188.26 | $573,253 |
| Sep 4, 2026 | Belite Bio Inc | Open-market sale | −8,955 | $189.34 | $1,695,552 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.